Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

Journal Article (Journal Article)

Soft tissue sarcomas (STS) are rare malignancies of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Soft Tissue Sarcoma provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as retroperitoneal/intra-abdominal STS, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis and treatment of retroperitoneal/intra-abdominal STS, outlines treatment recommendations, and reviews the evidence to support the guidelines recommendations.

Full Text

Duke Authors

Cited Authors

  • von Mehren, M; Kane, JM; Agulnik, M; Bui, MM; Carr-Ascher, J; Choy, E; Connelly, M; Dry, S; Ganjoo, KN; Gonzalez, RJ; Holder, A; Homsi, J; Keedy, V; Kelly, CM; Kim, E; Liebner, D; McCarter, M; McGarry, SV; Mesko, NW; Meyer, C; Pappo, AS; Parkes, AM; Petersen, IA; Pollack, SM; Poppe, M; Riedel, RF; Schuetze, S; Shabason, J; Sicklick, JK; Spraker, MB; Zimel, M; Hang, LE; Sundar, H; Bergman, MA

Published Date

  • July 2022

Published In

Volume / Issue

  • 20 / 7

Start / End Page

  • 815 - 833

PubMed ID

  • 35830886

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2022.0035


  • eng

Conference Location

  • United States